All lobbying filings

Ferox Strategies

Ferox Strategies filed a Q1 report for Stoke Therapeutics on April 17, 2026, reporting $40,000 in lobbying income.

Lobbying for Stoke Therapeutics · Biotechnology company

As filed: FEROX STRATEGIES for STOKE THERAPEUTICS.

All filings by Ferox Strategies · Everything Stoke Therapeutics has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

General issues related to rare disease treatment.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem